{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T03:00:32Z","timestamp":1773025232352,"version":"3.50.1"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["21662010"],"award-info":[{"award-number":["21662010"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["22061011"],"award-info":[{"award-number":["22061011"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81960628"],"award-info":[{"award-number":["81960628"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U1812403-05"],"award-info":[{"award-number":["U1812403-05"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004001","name":"Guizhou Science and Technology Department","doi-asserted-by":"publisher","award":["[2019]2760"],"award-info":[{"award-number":["[2019]2760"]}],"id":[{"id":"10.13039\/501100004001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010256","name":"Guangzhou Municipal Science and Technology Project","doi-asserted-by":"publisher","award":["[2017]30-18"],"award-info":[{"award-number":["[2017]30-18"]}],"id":[{"id":"10.13039\/501100010256","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.ejmech.2021.113799","type":"journal-article","created":{"date-parts":[[2021,8,27]],"date-time":"2021-08-27T11:06:02Z","timestamp":1630062362000},"page":"113799","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Cysteine derivatives as acetyl lysine mimics to inhibit zinc-dependent histone deacetylases for treating cancer"],"prefix":"10.1016","volume":"225","author":[{"given":"Jie","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhuoxian","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianxiong","family":"An","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaozhong","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5824-3975","authenticated-orcid":false,"given":"Ting","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongjun","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yonglong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hening","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bin","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ejmech.2021.113799_bib1","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/nrd.2017.219","article-title":"Mechanistic enzymology in drug discovery: a fresh perspective","volume":"17","author":"Holdgate","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"issue":"5460","key":"10.1016\/j.ejmech.2021.113799_bib2","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1126\/science.287.5460.1969","article-title":"Mechanism-based target identification and drug discovery in cancer research","volume":"287","author":"Gibbs","year":"2000","journal-title":"Science"},{"issue":"10229","key":"10.1016\/j.ejmech.2021.113799_bib3","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/S0140-6736(20)30164-1","article-title":"Small molecules, big impact: 20 years of targeted therapy in oncology","volume":"395","author":"Bedard","year":"2020","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.ejmech.2021.113799_bib4","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1016\/j.biotechadv.2014.08.005","article-title":"Advances in algal drug research with emphasis on enzyme inhibitors","volume":"32","author":"Rengasamy","year":"2014","journal-title":"Biotechnol. Adv."},{"issue":"22","key":"10.1016\/j.ejmech.2021.113799_bib5","doi-asserted-by":"crossref","first-page":"11194","DOI":"10.1021\/acs.chemrev.8b00369","article-title":"Enzymatic transition states and drug design","volume":"118","author":"Schramm","year":"2018","journal-title":"Chem. Rev."},{"issue":"4288","key":"10.1016\/j.ejmech.2021.113799_bib6","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1126\/science.191908","article-title":"Design of specific inhibitors of angiotensin-converting enzyme: new class of orally active antihypertensive agents","volume":"196","author":"Ondetti","year":"1977","journal-title":"Science"},{"issue":"25","key":"10.1016\/j.ejmech.2021.113799_bib7","doi-asserted-by":"crossref","first-page":"5484","DOI":"10.1021\/bi00644a014","article-title":"Design of potent competitive inhibitors of angiotensin-converting enzyme. Carboxyalkanoyl and mercapto-alkanoyl amino acids","volume":"16","author":"Cushman","year":"1977","journal-title":"Biochemistry"},{"issue":"7","key":"10.1016\/j.ejmech.2021.113799_bib8","doi-asserted-by":"crossref","first-page":"3957","DOI":"10.1073\/pnas.77.7.3957","article-title":"Mevinolin: a highly potent competitive inhibitor of hydroxymethylglutaryl-coenzyme A reductase and a cholesterol-lowering agent","volume":"77","author":"Alberts","year":"1980","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"6","key":"10.1016\/j.ejmech.2021.113799_bib9","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1021\/bi00327a014","article-title":"Mode of interaction of \u03b2-hydroxy-\u03b2-methylglutaryl coenzyme A reductase with strong binding inhibitors: compactin and related compounds","volume":"24","author":"Nakamura","year":"1985","journal-title":"Biochemistry"},{"issue":"3","key":"10.1016\/j.ejmech.2021.113799_bib10","doi-asserted-by":"crossref","first-page":"223","DOI":"10.2174\/1568026619666190122144949","article-title":"Zinc-dependent deacetylase (HDAC) inhibitors with different zinc binding groups","volume":"19","author":"Li","year":"2019","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113799_bib11","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1182\/blood-2006-06-025999","article-title":"Phase 2 trial of oral vorinostat (suberoylanilide hydroxamic acid, SAHA) for refractory cutaneous T-cell lymphoma (CTCL)","volume":"109","author":"Duvic","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.ejmech.2021.113799_bib12","doi-asserted-by":"crossref","first-page":"5410","DOI":"10.1200\/JCO.2008.21.6150","article-title":"Phase II multi-institutional trial of the histone deacetylase inhibitor romidepsin as monotherapy for patients with cutaneous T-cell lymphoma","volume":"27","author":"Piekarz","year":"2009","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.ejmech.2021.113799_bib13","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1517\/13543784.2011.629604","article-title":"Belinostat: clinical applications in solid tumors and lymphoma","volume":"20","author":"Molife","year":"2011","journal-title":"Expet Opin. Invest. Drugs"},{"key":"10.1016\/j.ejmech.2021.113799_bib14","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1586\/17474086.2015.983065","article-title":"Panobinostat: a review of trial results and future prospects in multiple myeloma","volume":"8","author":"Libby","year":"2015","journal-title":"Expet Rev. Hematol."},{"key":"10.1016\/j.ejmech.2021.113799_bib15","doi-asserted-by":"crossref","first-page":"493","DOI":"10.2174\/156800961506150805153230","article-title":"A\u00a0new strategy to target acute myeloid leukemia stem and progenitor cells using chidamide, a histone deacetylase inhibitor","volume":"15","author":"Li","year":"2015","journal-title":"Curr. Cancer Drug Targets"},{"issue":"11","key":"10.1016\/j.ejmech.2021.113799_bib16","doi-asserted-by":"crossref","first-page":"5138","DOI":"10.1021\/ja209574z","article-title":"Azalysine analogues as probes for protein lysine deacetylation and demethylation","volume":"134","author":"Dancy","year":"2012","journal-title":"J.\u00a0Am. Chem. Soc."},{"issue":"51","key":"10.1016\/j.ejmech.2021.113799_bib17","doi-asserted-by":"crossref","first-page":"37256","DOI":"10.1074\/jbc.M707878200","article-title":"Acetyl-lysine analog peptides as mechanistic probes of protein deacetylases","volume":"282","author":"Smith","year":"2007","journal-title":"J.\u00a0Biol. Chem."},{"issue":"6","key":"10.1016\/j.ejmech.2021.113799_bib18","article-title":"N\u03f5-acetyl lysine derivatives with zinc binding groups as novel HDAC inhibitors","volume":"6","author":"Wang","year":"2019","journal-title":"R.\u00a0Soc. Open Sci."},{"key":"10.1016\/j.ejmech.2021.113799_bib19","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms11262","article-title":"Insights into the activation mechanism of class I HDAC complexes by inositol phosphates","volume":"7","author":"Watson","year":"2016","journal-title":"Nat. Commun."},{"issue":"12","key":"10.1016\/j.ejmech.2021.113799_bib20","doi-asserted-by":"crossref","first-page":"2984","DOI":"10.1021\/jm030222i","article-title":"Antiproliferative and phenotype-transforming antitumor agents derived from cysteine","volume":"47","author":"Glenn","year":"2004","journal-title":"J.\u00a0Med. Chem."},{"issue":"26","key":"10.1016\/j.ejmech.2021.113799_bib21","doi-asserted-by":"crossref","first-page":"7611","DOI":"10.1021\/jm050214x","article-title":"Design, synthesis, potency, and cytoselectivity of anticancer agents derived by parallel synthesis from alpha-aminosuberic acid","volume":"49","author":"Kahnberg","year":"2006","journal-title":"J.\u00a0Med. Chem."},{"issue":"23","key":"10.1016\/j.ejmech.2021.113799_bib22","doi-asserted-by":"crossref","first-page":"7836","DOI":"10.1021\/jm900850t","article-title":"Discovery of potent and selective histone deacetylase inhibitors via focused combinatorial libraries of cyclic alpha3beta-tetrapeptides","volume":"52","author":"Olsen","year":"2009","journal-title":"J.\u00a0Med. Chem."},{"issue":"5","key":"10.1016\/j.ejmech.2021.113799_bib23","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.cell.2006.12.041","article-title":"The site-specific installation of methyl-lysine analogs into recombinant histones","volume":"128","author":"Simon","year":"2007","journal-title":"Cell"},{"issue":"20","key":"10.1016\/j.ejmech.2021.113799_bib24","doi-asserted-by":"crossref","first-page":"8358","DOI":"10.1021\/jm5008209","article-title":"ST7612AA1, a thioacetate-\u03c9(\u03b3-lactam carboxamide) derivative selected from a novel generation of oral HDAC inhibitors","volume":"57","author":"Giannini","year":"2014","journal-title":"J.\u00a0Med. Chem."},{"issue":"13","key":"10.1016\/j.ejmech.2021.113799_bib25","doi-asserted-by":"crossref","first-page":"5493","DOI":"10.1021\/acs.jmedchem.7b00197","article-title":"Design, multicomponent synthesis, and anticancer activity of a focused histone deacetylase (HDAC) inhibitor library with peptoid-based cap groups","volume":"60","author":"Krieger","year":"2017","journal-title":"J.\u00a0Med. Chem."},{"issue":"14","key":"10.1016\/j.ejmech.2021.113799_bib26","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1016\/j.bmcl.2018.06.030","article-title":"The mimics of N\u03b5-acyl-lysine derived from cysteine as sirtuin inhibitors","volume":"28","author":"Wang","year":"2018","journal-title":"Bioorg. Med. Chem. Lett"},{"issue":"3","key":"10.1016\/j.ejmech.2021.113799_bib27","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.ccell.2016.02.007","article-title":"A\u00a0SIRT2-selective inhibitor promotes c-myc oncoprotein degradation and exhibits broad anticancer activity","volume":"29","author":"Jing","year":"2016","journal-title":"Canc. Cell"},{"issue":"38","key":"10.1016\/j.ejmech.2021.113799_bib28","doi-asserted-by":"crossref","first-page":"7498","DOI":"10.1039\/C4OB00860J","article-title":"Thiomyristoyl peptides as cell-permeable Sirt6 inhibitors","volume":"12","author":"He","year":"2014","journal-title":"Org. Biomol. Chem."},{"issue":"4","key":"10.1016\/j.ejmech.2021.113799_bib29","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1021\/ja2090417","article-title":"Thiosuccinyl peptides as Sirt5-specific inhibitors","volume":"134","author":"He","year":"2012","journal-title":"J.\u00a0Am. Chem. Soc."},{"issue":"5","key":"10.1016\/j.ejmech.2021.113799_bib30","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.tips.2017.01.009","article-title":"Sirtuin inhibition: strategies, inhibitors, and therapeutic potential","volume":"38","author":"Jiang","year":"2017","journal-title":"Trends Pharmacol. Sci."},{"issue":"9","key":"10.1016\/j.ejmech.2021.113799_bib31","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1038\/sj.embor.7401047","article-title":"Substrate binding to histone deacetylases as shown by the crystal structure of the HDAC8-substrate complex","volume":"8","author":"Vannini","year":"2007","journal-title":"EMBO Rep."},{"issue":"7","key":"10.1016\/j.ejmech.2021.113799_bib32","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1016\/j.str.2004.04.012","article-title":"Structural snapshots of human HDAC8 provide insights into the class I histone deacetylases","volume":"12","author":"Somoza","year":"2004","journal-title":"Structure"},{"issue":"47","key":"10.1016\/j.ejmech.2021.113799_bib33","doi-asserted-by":"crossref","first-page":"14836","DOI":"10.1002\/anie.201709050","article-title":"Mechanism-based inhibitors of the human sirtuin 5 deacylase: structure-activity relationship, biostructural, and kinetic insight","volume":"56","author":"Rajabi","year":"2017","journal-title":"Angew Chem. Int. Ed. Engl."},{"issue":"17","key":"10.1016\/j.ejmech.2021.113799_bib34","doi-asserted-by":"crossref","first-page":"7974","DOI":"10.1021\/acs.jmedchem.6b00772","article-title":"Synthesis and antileukemic activities of piperlongumine and HDAC inhibitor hybrids against acute myeloid leukemia cells","volume":"59","author":"Liao","year":"2016","journal-title":"J.\u00a0Med. Chem."},{"issue":"W1","key":"10.1016\/j.ejmech.2021.113799_bib35","doi-asserted-by":"crossref","first-page":"W200","DOI":"10.1093\/nar\/gkv353","article-title":"FAF-Drugs3: a web server for compound property calculation and chemical library design","volume":"43","author":"Lagorce","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ejmech.2021.113799_bib36","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ejmech.2018.07.069","article-title":"Novel spiroindoline HDAC inhibitors: synthesis, molecular modelling and biological studies","volume":"157","author":"Brindisi","year":"2018","journal-title":"Eur. J. Med. Chem."},{"issue":"4","key":"10.1016\/j.ejmech.2021.113799_bib37","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1021\/jm200799p","article-title":"Dual targeting of histone deacetylase and topoisomerase II with novel bifunctional inhibitors","volume":"55","author":"Guerrant","year":"2012","journal-title":"J.\u00a0Med. Chem."},{"issue":"6749","key":"10.1016\/j.ejmech.2021.113799_bib38","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1038\/43710","article-title":"Structures of a histone deacetylase homologue bound to the TSA and SAHA inhibitors","volume":"401","author":"Finnin","year":"1999","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.ejmech.2021.113799_bib39","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1038\/nchembio.2134","article-title":"Histone deacetylase 6 structure and molecular basis of catalysis and inhibition","volume":"12","author":"Hai","year":"2016","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.ejmech.2021.113799_bib40","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"Improving the speed and accuracy of docking with a new scoring function, efficient optimization and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J.\u00a0Comput. Chem."},{"key":"10.1016\/j.ejmech.2021.113799_bib41","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1002\/jcc.21256","article-title":"AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility","volume":"30","author":"Morris","year":"2009","journal-title":"J.\u00a0Comput. Chem."},{"key":"10.1016\/j.ejmech.2021.113799_bib42","doi-asserted-by":"crossref","first-page":"5905","DOI":"10.2147\/IJN.S114205","article-title":"Acute and subacute toxicity profiles of thymoquinone-loaded nanostructured lipid carrier in BALB\/c mice","volume":"11","author":"Ong","year":"2016","journal-title":"Int. J. Nanomed."},{"issue":"7","key":"10.1016\/j.ejmech.2021.113799_bib43","doi-asserted-by":"crossref","first-page":"3166","DOI":"10.1021\/acs.jmedchem.8b00209","article-title":"Discovery of N1-(4-((7-Cyclopentyl-6-(dimethylcarbamoyl)-7H-pyrrolo[2,3-d]pyrimidin-2-yl)amino)phenyl)- N8-hydroxyoctanediamide as a novel inhibitor targeting cyclin-dependent kinase 4\/9 (CDK4\/9) and histone Deacetlyase1 (HDAC1) against malignant cancer","volume":"61","author":"Li","year":"2018","journal-title":"J.\u00a0Med. Chem."},{"issue":"21","key":"10.1016\/j.ejmech.2021.113799_bib44","doi-asserted-by":"crossref","first-page":"4609","DOI":"10.1021\/jm030235w","article-title":"N-hydroxy-3-phenyl-2-propenamides as novel inhibitors of human histone deacetylase with in\u00a0vivo antitumor activity: discovery of (2E)-N-hydroxy-3-[4-[[(2-hydroxyethyl)[2-(1H-indol-3-yl)ethyl]amino]methyl]phenyl]-2-propenamide (NVP-LAQ824)","volume":"46","author":"Remiszewski","year":"2003","journal-title":"J.\u00a0Med. Chem."},{"issue":"21","key":"10.1016\/j.ejmech.2021.113799_bib45","doi-asserted-by":"crossref","first-page":"9067","DOI":"10.1021\/acs.jmedchem.7b01444","article-title":"Controlling plasma stability of hydroxamic acids: a MedChem toolbox","volume":"60","author":"Hermant","year":"2017","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113799_bib46","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1002\/(SICI)1096-987X(199604)17:5\/6<490::AID-JCC1>3.0.CO;2-P","article-title":"Merck molecular force field. I. Basis, form, scope, parameterization, and performance of MMFF94","volume":"17","author":"Halgren","year":"1996","journal-title":"J.\u00a0Comput. Chem."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523421006486?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523421006486?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T14:36:10Z","timestamp":1759329370000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523421006486"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":46,"alternative-id":["S0223523421006486"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2021.113799","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cysteine derivatives as acetyl lysine mimics to inhibit zinc-dependent histone deacetylases for treating cancer","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2021.113799","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"113799"}}